Given full information about the risks of long-term opioid therapy, patients often see the value of exploring other options rather than thinking their physicians are reluctant to prescribe narcotics for fear of litigation or regulatory action.
AMA J Ethics. 2015;17(3):202-208. doi:
10.1001/journalofethics.2015.17.3.ecas1-1503.
The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.
Tomas Diaz, MD, Ryan Huerto, MD, MPH, MA, and Jasmine Weiss, MD
Aligning merit-based approaches with holistic approaches and equitable candidate evaluation can improve admissions processes, support learners, and improve patient care.
AMA J Ethics. 2021;23(3):E223-228. doi:
10.1001/amajethics.2021.223.